1. 37 CAR, A NOVEL MEDIATOR OF ERYTHROID DIFFERENTIATION AND MIGRATION, IS SPECIFICALLY DOWNREGULATED IN ERYTHROPOIETIC PROGENITOR CELLS IN MDS. (April 2015) Authors: Bauer, K.; Machherndl-Spandl, S.; Suessner, S.; Danzer, M.; Proell, J.; Lauf, J.; Eisenwort, G.; Sperr, W.; Klein, H.; Hoermann, G.; Haefner, N.; Bene, M.; Platzbecker, U.; Weltermann, A.; Gabriel, C.; Lion, T.; Germing, U.; Bettelheim, P.; Valent, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB). Issue 3 (1st February 2018) Authors: Gebhart, J.; Hofer, S.; Panzer, S.; Quehenberger, P.; Sunder‐Plassmann, R.; Hoermann, G.; Eigenbauer, E.; Haslacher, H.; Kepa, S.; Kyrle, P. A.; Eichinger, S.; Knöbl, P.; Eischer, L.; Mannhalter, C.; Ay, C.; Pabinger, I. Journal: Haemophilia Issue: Volume 24:Issue 3(2018) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IL‐4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells. (9th August 2016) Authors: Bauer, K.; Hadzijusufovic, E.; Cerny‐Reiterer, S.; Hoermann, G.; Reifinger, M.; Pirker, A.; Valent, P.; Willmann, M. Journal: Veterinary and comparative oncology Issue: Volume 15:Number 4(2017:Dec.) Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oncostatin M is a FIP1L1/PDGFRA‐dependent mediator of cytokine production in chronic eosinophilic leukemia. Issue 6 (27th April 2013) Authors: Hoermann, G.; Cerny‐Reiterer, S.; Sadovnik, I.; Müllauer, L.; Bilban, M.; Gröger, M.; Horny, H.‐P.; Reiter, A.; Schmitt‐Graeff, A.; Mannhalter, C.; Valent, P.; Mayerhofer, M. Journal: Allergy Issue: Volume 68:Issue 6(2013:Jun.) Page Start: 713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P411: SF3B1 MUTATIONS IN AML ARE STRONGLY ASSOCIATED WITH MECOM REARRANGEMENTS AND MAY BE INDICATIVE OF AN MDS PRE-PHASE. (23rd June 2022) Authors: Huber, S.; Hutter, S.; Meggendorfer, M.; Hoermann, G.; Walter, W.; Baer, C.; Kern, W.; Haferlach, T.; Haferlach, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P735: THE ROLE OF SF3B1 MUTATIONS IN MYELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Huber, S.; Hutter, S.; Meggendorfer, M.; Hoermann, G.; Walter, W.; Baer, C.; Kern, W.; Haferlach, T.; Haferlach, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease. Issue 6 (17th April 2014) Authors: Hoermann, G.; Gleixner, K. V.; Dinu, G. E.; Kundi, M.; Greiner, G.; Wimazal, F.; Hadzijusufovic, E.; Mitterbauer, G.; Mannhalter, C.; Valent, P.; Sperr, W. R. Journal: Allergy Issue: Volume 69:Issue 6(2014:Jun.) Page Start: 810 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗